CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenue
Operating expenses
Research and development	596,254	1,054,293
General and administrative	1,146,556	(537,044)
Total operating expenses, net	(1,742,810)	517,249
Loss from operations		(517,249)
Other income
Interest income	950	7
Other income	14,815
Interest expense	(289)
Total other income	15,476	7
Net loss	$ (1,727,334)	$ (517,242)
Basic and Diluted Loss per Common Share	$ (0.02)	$ (0.01)
Weighted average number of common shares outstanding - basic and diluted	87,352,364	87,352,364